PD-1 /PD L-1 checkpoint inhibitor is the new hope for Cancer Treatment
What are Checkpoint inhibitors? Checkpoint inhibitors are a group of proteins that can treat cancer potentially. Checkpoint inhibitor therapy is a form of cancer immunotherapy that targets immune checkpoint. Immune checkpoints are the immune regulators, as the name denotes itself, that regulate or control the activity of immune cells, enhancing the self-tolerance of the immune system. These inhibitors when stimulated hampers the immune response to an immunologic stimulus. Checkpoint Therapy to combat Cancer Some cancerous cells do protect themselves from getting attacked by activating the immune checkpoint targets. Once activated, they block the inhibitory checkpoints, and restore the functioning of the immune checkpoints. CTLA-4 inhibitors, PD-1 inhibitors and PD-L1 inhibitors are the checkpoint inhibitors that are used to treat cancers. PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors that are present on the surface of ...